The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis

NCT05633563 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Transthyretin Amyloid Cardiopathy
Mitochondrial Pathology

Interventions

DRUG: Trimetazidine
DRUG: Placebo

Sponsor

Steen Hvitfeldt Poulsen